National Eye Institute; Notice of Closed Meeting, 57964-57965 [2023-18184]

Download as PDF 57964 Federal Register / Vol. 88, No. 163 / Thursday, August 24, 2023 / Notices All nominations should be emailed in one email to PACHA@ hhs.gov with the subject line ‘‘PACHA Application 2024.’’ ADDRESSES: Ms. Caroline Talev, Senior Management Analyst and Alternate Designated Federal Officer to PACHA; email Caroline.Talev@hhs.gov and include in the subject line ‘‘PACHA Application 2024’’ or please call 202–795–7697. Additional information about PACHA can be obtained by accessing the Council’s website at About PACHA | HIV.gov. FOR FURTHER INFORMATION CONTACT: PACHA was established by Executive Order 12963, dated June 14, 1995 as amended by Executive Order 13009, dated June 14, 1996. Under a Presidential memorandum, dated July 13, 2000 and under Executive Order 13703, dated July 30, 2015, certain authorities were given to the PACHA for the implementation of the National HIV/ AIDS Strategy for the United States (Strategy or NHAS). The Council was continued by Executive Order 14048, dated September 30, 2021. The Council was established to provide advice, information, and recommendations to the Secretary regarding programs and policies intended to promote effective prevention of HIV disease and AIDS. The functions of the Council are solely advisory in nature. The Council consists of not more than 35 members. Council members are selected from prominent community leaders with particular expertise in, or knowledge of, matters concerning HIV and AIDS, public health, global health, population health, faith, philanthropy, marketing or business, as well as other national leaders held in high esteem from other sectors of society. PACHA selections will also include persons with lived HIV experience and racial/ethnic and sexual and gender minority persons disproportionately affected by HIV. Council members are appointed by the Secretary. Pursuant to advance written agreement, Council members shall receive no stipend for the advisory service they render as members of PACHA. However, as authorized by law and in accordance with Federal travel regulations, PACHA members may receive per diem and reimbursement for travel expenses incurred in relation to performing duties for the Council. This announcement is to solicit nominations of qualified candidates to fill current and upcoming vacancies on the PACHA. lotter on DSK11XQN23PROD with NOTICES1 SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:08 Aug 23, 2023 Jkt 259001 Nominations Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of PACHA’s objectives. Federal employees will not be considered for membership. The membership of the Committee will reflect diverse individuals. To ensure that the Commission membership is fairly balanced in terms of the points of view presented, consideration is also given to organizations representing the health interest of racial and ethnic minority groups. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Committee members are Special Government Employees (SGEs), requiring the filing of financial disclosure reports at the beginning and annually during their terms. Individuals who are selected for appointment will be required to provide detailed information regarding their financial interests. Note that the need for different expertise varies from year to year and a candidate who is not selected for an open position may be reconsidered for a subsequent open position. SGE nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items to be considered of appointment: • Current curriculum vitae or resume, including complete contact information (telephone numbers, mailing address, email address). • A biographical sketch of the nominee (200 words or fewer). • A letter of interest or personal statement from the nominee stating how their expertise would inform the work of PACHA. • At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. Individuals can nominate themselves for consideration of appointment to the Council. All nominations must include the required information in one email sent to PACHA.hhs.gov with the subject line, ‘‘PACHA Application 2024.’’ Incomplete nomination applications will not be processed for consideration. The Department is legally required to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the functions to be performed by the advisory committee. PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Appointment to the Council shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. The Standards of Ethical Conduct for Employees of the Executive Branch are applicable to individuals who are appointed as members of the Council. Dated: August 21, 2023. Caroline Talev, Senior Management Analyst, Alternate Designated Federal Officer, PACHA, Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services. [FR Doc. 2023–18261 Filed 8–23–23; 8:45 am] BILLING CODE 4150–43–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; K99 Training Grant Applications. Date: September 13, 2023. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 6700B Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ashley Fortress, Ph.D., Designated Federal Official, Division of Extramural Activities, National Eye Institute, National Institutes of Health, 6700 B Rockledge Dr., Bethesda, MD 20817 (301) 451–2020, ashley.fortress@nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.867, Vision Research, National Institutes of Health, HHS) E:\FR\FM\24AUN1.SGM 24AUN1 Federal Register / Vol. 88, No. 163 / Thursday, August 24, 2023 / Notices Dated: August 18, 2023. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18184 Filed 8–23–23; 8:45 am] BILLING CODE 4140–01–P (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 21, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2023–18264 Filed 8–23–23; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P Center for Scientific Review; Notice of Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Scientific Review Advisory Council. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should register at: https://public.csr.nih.gov/ AboutCSR/Organization/ CSRAdvisoryCouncil/Registration. The meeting can be viewed remotely via the NIH Videocasting website: https://videocast.nih.gov/watch=52210. Name of Committee: Center for Scientific Review Advisory Council. Date: September 18, 2023. Time: 9:00 a.m. to 3:30 p.m. Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Conference room 270 A&B, Bethesda, MD 20892 (Hybrid Meeting). Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–9159, reedbr@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has stringent procedures for entrance into NIH federal property. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// public.csr.nih.gov/AboutCSR/Organization/ CSRAdvisoryCouncil, where an agenda and any additional information for the meeting will be posted when available. VerDate Sep<11>2014 17:08 Aug 23, 2023 Jkt 259001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Advisory Committee for Women’s Services (ACWS); Solicitation of Nominations for Additional Non-Voting Representatives on the Maternal Mental Health Task Force Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services. ACTION: Notice. AGENCY: The Substance Abuse and Mental Health Services Administration (SAMHSA) within the Department of Health and Human Services (HHS), is soliciting applications from qualified individuals or organizations to be considered for non-voting representative positions on the Maternal Mental Health Task Force subcommittee of the Advisory Committee for Women’s Services (ACWS) (ACWS Subcommittee), as authorized in the Consolidated Appropriations Act. This notice solicits additional representatives. DATES: Nomination period is open until September 22, 2023. ADDRESSES: All nominations should be sent to Valerie Kolick, Designated Federal Officer (DFO), Advisory Committee on Women’s Services, SAMHSA, 18th Floor, 5600 Fishers Ln., Rockville, MD 20857. Nomination materials, including attachments, may be submitted electronically to valerie.kolick@samhsa.hhs.gov. FOR FURTHER INFORMATION CONTACT: Valerie Kolick, Designated Federal Officer, Advisory Committee on Women’s Services, SAMHSA, 5600 Fishers Ln., Rockville, MD 20857. Telephone number (240) 276–1738. Inquiries can be sent to valerie.kolick@ samhsa.hhs.gov. SUPPLEMENTARY INFORMATION: As previously announced in 88 FR 24622 (Apr. 21, 2023), the ACWS SUMMARY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 57965 Subcommittee will consist of non-voting representatives selected by the ACWS DFO. We are issuing this current notice to solicit additional representatives to the ACWS Subcommittee. The ACWS’s role is to advise the Associate Administrator for Women’s Services (AAWS) on appropriate activities to be undertaken by the agencies of the Administration with respect to women’s substance use and mental health services, including services which require a multidisciplinary approach. These may include discussion on the development of policies and programs regarding women’s issues; plans to standardize and enhance the collection of data on women’s health, and other emerging issues concerning women’s substance use and mental health services. Management and support services for Committee activities are provided by staff from the HHS SAMHSA. The ACWS charter is available at https:// www.samhsa.gov/about-us/advisorycouncils/acws/committee-charter. The ACWS meetings are held not less than two times per fiscal year. Subcommittees of the ACWS may be established with the approval of the Assistant Secretary or the AAWS. The advice/recommendations of a subcommittee must be deliberated by the parent committee. A subcommittee may not provide advice or work products directly to the agency. The Department Committee Management Officer will be notified upon the establishment of each subcommittee and will be provided information on its name, membership, function, and estimated frequency of meetings. In particular, this subcommittee will focus on maternal mental health and substance use including prevention, screening, diagnosis, treatment, equity and community-based interventions. These non-voting positions will consist of: Federal members to include representatives of: Department of Health and Human Services, Substance Abuse Mental Health Services Administration, Assistant Secretary for Planning and Evaluation, Administration for Children and Families, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Health Resources and Services Administration, Indian Health Services, and other Federal departments as necessary. Non-Federal members to include representatives of the following with expertise in maternal, mental health, and/or substance use: professional medical societies, professional nursing societies, and/or health paraprofessional societies, nonprofit organizations, E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 88, Number 163 (Thursday, August 24, 2023)]
[Notices]
[Pages 57964-57965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18184]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Eye Institute; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Eye Institute Special Emphasis 
Panel; K99 Training Grant Applications.
    Date: September 13, 2023.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Eye Institute, 6700B Rockledge Drive, Bethesda, 
MD 20892 (Virtual Meeting).
    Contact Person: Ashley Fortress, Ph.D., Designated Federal 
Official, Division of Extramural Activities, National Eye Institute, 
National Institutes of Health, 6700 B Rockledge Dr., Bethesda, MD 
20817 (301) 451-2020, [email protected].

(Catalogue of Federal Domestic Assistance Program No. 93.867, Vision 
Research, National Institutes of Health, HHS)


[[Page 57965]]


    Dated: August 18, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-18184 Filed 8-23-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.